What do you wish you’d invented?
The internet. It has effectively enabled a new age of man – the Information Age.
The internet has democratised healthcare, enabling people to be much more engaged in health and lifestyle decision-making, and much more informed about the medicines that they take.
What trend do you see shaping the industry?
As patient engagement and activism increases, HCP, payers and policy makers must see the patient value story to reimburse and use medicines and services.
Companies have to bring the patient to the heart of their processes from discovery to commercialisation. Some are moving faster than others.
I believe that all companies need to ensure that they truly understand the needs and values of the patients that they serve, and ensure these insights drive everything that they do.
What has made you proud in your career?
Positive feedback and follow-on work is always gratifying, as it shows that the work that you do is useful and valued.
Seeing processes, tools and initiatives in use in the months and years after you worked on them is also rewarding, when you can clearly see that they have enabled our clients to work more effectively or productively.
Where were you before?
I studied Academic research (PhD) at King’s College London, doing preclinical research on a drug candidate for the treatment of serious side effects of Parkinson’s Disease therapy (L-dopa).
Following that, my first job was as both Project Manager and Business Development Manager at a Pharmaceutical marketing consultancy that specialises in Key Opinion Leader market research and profiling.
Why did you choose to work in the life sciences industry?
It started with a love of science. It continues with a desire to support the industry to effectively deliver on its mission to develop medicines and services that improve people’s lives.